• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 27-07-2026: General Updates

    27-07-2026 | 04:00 pm

    Sun Pharma's partner Philogen resubmitted Nidlegy's market approval application to EMA for melanoma treatment. Updated Phase III data showed reduced relapse/death risk. This key development advances the skin cancer therapy for Europe, NZ, and Australian markets.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited